Silvia Jiménez

2.5k total citations · 1 hit paper
39 papers, 1.6k citations indexed

About

Silvia Jiménez is a scholar working on Epidemiology, Surgery and Oncology. According to data from OpenAlex, Silvia Jiménez has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Surgery and 8 papers in Oncology. Recurrent topics in Silvia Jiménez's work include Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (13 papers) and Genital Health and Disease (10 papers). Silvia Jiménez is often cited by papers focused on Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (13 papers) and Genital Health and Disease (10 papers). Silvia Jiménez collaborates with scholars based in United States, Costa Rica and Spain. Silvia Jiménez's co-authors include Rolando Herrero, Carolina Porras, Allan Hildesheim, Paula González, Wim Quint, Aimée R. Kreimer, Sholom Wacholder, Douglas R. Lowy, John T. Schiller and Ana Cecilia Rodríguez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Silvia Jiménez

34 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

2013 350 citations Rolando Herrero, Wim Quint et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Jiménez United States	17	1.1k	575	316	263	187	39	1.6k
Manuel Quiterio Mexico	25	1.2k 1.0×	871 1.5×	130 0.4×	161 0.6×	71 0.4×	45	1.6k
Sara Tous Spain	19	1.2k 1.1×	707 1.2×	183 0.6×	240 0.9×	103 0.6×	47	1.5k
Joseph E. Tota United States	18	836 0.7×	421 0.7×	218 0.7×	244 0.9×	72 0.4×	51	1.2k
John Schussler United States	19	1.9k 1.7×	794 1.4×	106 0.3×	327 1.2×	202 1.1×	35	2.0k
Tatevik Broutian United States	10	1.0k 0.9×	420 0.7×	1.1k 3.4×	338 1.3×	74 0.4×	12	1.7k
Elmar A. Joura Austria	31	2.2k 2.0×	1.3k 2.3×	74 0.2×	462 1.8×	308 1.6×	128	3.3k
Yaqi Pan China	21	381 0.3×	533 0.9×	95 0.3×	414 1.6×	80 0.4×	84	1.2k
Hélène Péré France	20	493 0.4×	266 0.5×	182 0.6×	551 2.1×	473 2.5×	84	1.8k
Alessandra Latini Italy	19	457 0.4×	303 0.5×	72 0.2×	176 0.7×	71 0.4×	94	1.2k
Jennifer Webster‐Cyriaque United States	24	703 0.6×	222 0.4×	152 0.5×	836 3.2×	233 1.2×	56	1.7k

Countries citing papers authored by Silvia Jiménez

Since Specialization

Citations

This map shows the geographic impact of Silvia Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Jiménez more than expected).

Fields of papers citing papers by Silvia Jiménez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Jiménez. The network helps show where Silvia Jiménez may publish in the future.

Co-authorship network of co-authors of Silvia Jiménez

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Jiménez. A scholar is included among the top collaborators of Silvia Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Jiménez. Silvia Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiménez, Silvia, Inmaculada Mora-Jiménez, Margarita Garrido, et al.. (2024). First-line pembrolizumab for lung cancer in a Spanish real-world study.. Journal of Clinical Oncology. 42(16_suppl). e23268–e23268. 1 indexed citations

García‐Sánz, Ramón, Anna Sureda, Fátima De la Cruz, et al.. (2019). Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group). Annals of Oncology. 30(4). 612–620. 78 indexed citations

Kreimer, Aimée R., Rolando Herrero, Joshua N. Sampson, et al.. (2018). Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies. Vaccine. 36(32). 4774–4782. 97 indexed citations

Vigués, Núria, et al.. (2016). Paper-based chromatic toxicity bioassay by analysis of bacterial ferricyanide reduction. Analytica Chimica Acta. 910. 60–67. 15 indexed citations

Roldán, Inmaculada, et al.. (2016). A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation. Cardiology and Therapy. 5(2). 171–186. 18 indexed citations

Beachler, Daniel C., Aimée R. Kreimer, Mark Schiffman, et al.. (2015). Abstract 4680: Efficacy of the HPV16/18 vaccine against cervical, anal, and oral HPV infection among women with and without previous HPV16/18 exposure. Cancer Research. 75(15_Supplement). 4680–4680.

Porras, Carolina, Allan Hildesheim, Paula González, et al.. (2014). Performance of Self-Collected Cervical Samples in Screening for Future Precancer Using Human Papillomavirus DNA Testing. JNCI Journal of the National Cancer Institute. 107(1). dju400–dju400. 25 indexed citations

Kuhs, Krystle A. Lang, Paula González, Ana Cecilia Rodríguez, et al.. (2014). Reduced Prevalence of Vulvar HPV16/18 Infection Among Women Who Received the HPV16/18 Bivalent Vaccine: A Nested Analysis Within the Costa Rica Vaccine Trial. The Journal of Infectious Diseases. 210(12). 1890–1899. 18 indexed citations

Herrero, Rolando, Wim Quint, Allan Hildesheim, et al.. (2013). Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica. PLoS ONE. 8(7). e68329–e68329. 350 indexed citations breakdown →

10.

Rodríguez, Ana Cecilia, D. Solomon, Rolando Herrero, et al.. (2013). Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment. American Journal of Epidemiology. 178(5). 752–760. 20 indexed citations

11.

Porras, Carolina, Jesse Nodora, Rachael Sexton, et al.. (2012). Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes & Control. 24(2). 209–215. 111 indexed citations

12.

Herrero, Rolando, Sholom Wacholder, Ana Cecilia Rodríguez, et al.. (2011). Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica. Cancer Discovery. 1(5). 408–419. 116 indexed citations

13.

Porras, Carolina, Lori E. Dodd, Allan Hildesheim, et al.. (2011). Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure. Sexually Transmitted Diseases. 38(10). 976–982. 16 indexed citations

14.

Jiménez, Silvia, et al.. (2010). Parteras tradicionales y su relación con las instituciones de salud. Entre la resistencia y la subordinación. Revista Chilena de Salud Pública. 12(3). 161–168. 4 indexed citations

15.

Porras, Carolina, Christina N. Bennett, Mahboobeh Safaeian, et al.. (2010). Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infectious Diseases. 10(1). 238–238. 27 indexed citations

16.

Cortés, Bernal, Mark Schiffman, Rolando Herrero, et al.. (2010). Establishment and Operation of a Biorepository for Molecular Epidemiologic Studies in Costa Rica. Cancer Epidemiology Biomarkers & Prevention. 19(4). 916–922. 8 indexed citations

17.

Jiménez, Silvia. (2009). La radio en internet. De la ciberradio a las redes sociales y a la radio móvil. 6(1). 137–138.

18.

Perez, María J., et al.. (2008). Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy. Toxicology and Applied Pharmacology. 232(2). 327–336. 12 indexed citations

19.

Macı́as, Rocı́o I.R., Silvia Jiménez, María A. Serrano, María J. Monte, & José J.G. Marı́n. (2006). Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sciences. 79(10). 1014–1019. 8 indexed citations

20.

Macı́as, Rocı́o I.R., et al.. (2005). Long-Term Effect of Treating Pregnant Rats with Ursodeoxycholic Acid on the Congenital Impairment of Bile Secretion Induced in the Pups by Maternal Cholestasis. Journal of Pharmacology and Experimental Therapeutics. 312(2). 751–758. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact